Health Behavior Clinical Trial
Official title:
Effects of Microbouts of Activity on Metabolic Health
NCT number | NCT02998892 |
Other study ID # | 16-1769 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 9, 2017 |
Est. completion date | October 8, 2021 |
Verified date | January 2022 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Population studies suggest that time spent in sedentary behaviors is associated with all-cause mortality including obesity, diabetes, and cardiovascular diseases, independent of time spent in exercise. Frequent interruptions to sedentary time are however beneficially associated with metabolic health outcomes, even in individuals who exercise regularly. The goal is to use integrative approach to understand the biological mechanisms that underlie these associations in a longitudinal intervention study in overweight sedentary adults. The investigators believe that the proposed study will provide an initial evidence base for the health benefits of breaking up prolonged sitting with short bursts of activity. This innovative strategy may be more effective at combating the adverse effects of sedentary behaviors than more traditional approaches.
Status | Completed |
Enrollment | 32 |
Est. completion date | October 8, 2021 |
Est. primary completion date | October 8, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Overweight but weight stable (+/- 3kg over previous 6 months) sedentary male and female adults (n=30) will be recruited. - Ages between 18-45 years old - BMI of 25-35 kg/m2 - Sedentary (< 1hr/wk of moderate-to-vigorous activity, less than 6,500 steps per day as measured for 5 days in free-living conditions with a pedometer). Based on subjects self-report during the H&P visit - The use of birth pill control will be accepted Exclusion criteria: - Any history of renal (present or past kidney failure, kidney transplant, dialysis or kidney cysts), - Uncontrolled hypertension - Cardiovascular (present or past atherosclerosis, heart attack, ischemic stroke, heart failure) - Hepatic diseases (past or present hepatitis B or C, fibrosis, cirrhosis, NAFLD/NASH) - Type 1 or 2 diabetes - Cancer - Smoking - Consumption of drugs (marijuana included) - Consumption of alcohol (>40g/d) - HIV positivity - Psychiatric disorders - Any medications known to interfere with lipid or energy metabolism - Known physical activity contraindications - Major illness/physical problems (acute or chronic) that may limit their ability to perform the walking activities - The blood draw will be used to objectively exclude peri- or postmenopausal women (FSH>25 mlU/mL in early follicular phase) - Hypertriglyceridemia (triglycerides > 400mg/dL). |
Country | Name | City | State |
---|---|---|---|
United States | University of Colorado Hospital | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in sedentary time as measured by ActiPAL | Over each 2 week period, participants will be instructed to wear an ActiPAL (PALTechnologies: Glasgow, Scotland) activity monitor on their right leg. Participants will be instructed to wear the monitors at all times except when sleeping or participating in water-based activities. The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day. | weeks 1-2 and weeks 5-6 | |
Primary | Changes in total substrate oxidation | Total fat oxidation during the test day will be determined using whole-room indirect calorimetry. O2 consumption and CO2 production will be determined from the flow rates and differences in gas concentrations between air entering and air exiting the calorimeter as previously described | week 2 and week 7 | |
Primary | Changes in insulin sensitivity | Insulin sensitivity will be determined via an insulin modified frequently sampled intra-venous glucose tolerance test (IVGTT). After baseline samples, intravenous glucose (0.3 g/kg) will be infused over 1 minute, followed by insulin at 0.03 U/kg, 20 minutes after glucose administration. Blood samples will be frequently sampled over 5 hours, and insulin sensitivity will be calculated using the Bergman minimal model. | week 2 and week 7 | |
Secondary | Changes in total energy expenditure (TEE) | Total energy expenditure (TEE) will be measured before and at the end of the intervention using doubly labeled water (DLW) over a 10-day period, as previously described (31). Subjects will ingest premixed 2g/kg total body water (TBW), estimated as 73% of fat free mass) dose of DLW composed of 0.2 and 0.15 g/kg estimated TBW of H218O and 2H2O, respectively. Urine samples will be collected in duplicate on days 0, 6, 8 and 10. 2H and 18O enrichment will be determined in urine samples by isotope ratio mass spectrometry (Delta V Advantage IRMS) | week 1-2 and week 5-6 | |
Secondary | Changes in Moderate-to-vigorous physical activity as measured by ActiGraph | Over the same 10-day period, participants will be instructed to wear an Actigraph GT3X+ accelerometer (Actigraph, LLC, Fort Walton Beach, FL) on their hip. Participants will be instructed to wear the monitors at all times except when sleeping or participating in water-based activities. | weeks 1-6 | |
Secondary | Changes in plasma CRP concentration | Weekly fasting blood samples will be obtained for the measurements of CRP (mg/dL). | Once weekly for 5 weeks | |
Secondary | Changes in Dietary Carbohydrate Oxidation | After the investigators have shown the subjects the procedure, subjects will collect their own hourly breath sampling for CO2 by blowing through a straw into two 15ml Vacutainers. Breath CO2 will be sampled directly from the Vacutainer with a syringe, and 13CO2 /12CO2 measured with IRMS. | week 2 and week 7 | |
Secondary | Changes in Dietary Fat Oxidation | Hourly urine sampling will be collected by the subjects for 24 hours and stored in 5mL cryovials at -20C until further analysis. To measure 2 hour fat oxidation, 2 hour/1 hour ratios from urine samples will be analyzed, as above described for the doubly labeled water method. The oxidation rate of glucose/water will be calculated from the cumulative recovery of 2 hours in total body water (TBW) as detailed previously. | week 2 and week 7 | |
Secondary | Changes in Mitochondria function | Freshly isolated skeletal muscle biopsies will be cut into small samples, the fibre bundles separated mechanically and partially teased apart and permeabilised. Small samples (2-5mg) will be added to the 2ml chamber of an Oroboros high-resolution respirometer with a mitochondrial respiration buffer. With the addition of several substrates, different states will be reached to analyse mitochondrial function. Pyruvate, malate and glutamate will be added as substrates to examine respiration through Complex I, succinate will be used to examine respiration through Complex II and octanoylcarnitine will be used to examine respiration through the electron-transferring flavoprotein, ETF. | week 2 and week 7 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
Recruiting |
NCT04356924 -
Psychological Treatment to Support the Consequences of Cognitive Impairment
|
N/A | |
Completed |
NCT05509049 -
Precision Nudging Drives Wellness Visit Attendance at Scale
|
N/A | |
Completed |
NCT03904992 -
Intervention With a Progressive Web App for the Promotion of Healthy Habits in Preschoolers
|
N/A | |
Completed |
NCT05509270 -
Efficacy of Communication Modalities for Promoting Flu Shots
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03081520 -
Affective Responses Following Aerobic Exercise With Different Intensities
|
N/A | |
Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
Completed |
NCT03982095 -
Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer
|
||
Completed |
NCT02777086 -
Sustainable HIV Risk Reduction Strategies for Probationers
|
N/A | |
Completed |
NCT02996864 -
Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Active, not recruiting |
NCT04152824 -
Readiness Supportive Leadership Training
|
N/A | |
Recruiting |
NCT05541653 -
The IGNITE Study on Concentrated Investment in Black Neighborhoods
|
N/A | |
Completed |
NCT03875768 -
Nourish: A Digital Health Program to Promote the DASH Eating Plan Among Adults With High Blood Pressure
|
N/A | |
Completed |
NCT04089020 -
Walking to School Supports
|
N/A | |
Completed |
NCT03646903 -
Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk
|
N/A | |
Completed |
NCT03548077 -
POWERPLAY: Promoting Men's Health at Work
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Completed |
NCT06365450 -
Breast and Cervical Cancer Education Program
|
N/A |